Pneumonia

>

Latest News

Topline results for VAXNEUVANCE™ study in healthy infants announced
Topline results for VAXNEUVANCE™ study in healthy infants announced

August 25th 2021

Merck has released promising topline results from their study of VAXNEUVANCE™, a 15-valent pneumococcal conjugate vaccine, in infants.

child with respiratory disease
How location of care impacts prescriptions for pneumonia and sinusitis

July 7th 2020

Pneumonia: Update on Causes--and Treatment Options

September 1st 2005

© 2023 MJH Life Sciences

All rights reserved.